Dr. Pallavi Buddhadev Manvar-Singh, MD

Dr. Manvar-Singh practices at All Care Medical of NY, P.C. in New Hyde Park, New York.

Dr. Manvar-Singh's NPI, 1366686255, was assigned on April 23, 2009. Dr. Manvar-Singh holds New York license 274124-1.

Dr. Manvar-Singh's primary practice is All Care Medical of NY, P.C., at 2001 Marcus Ave, New Hyde Park, NY 11042 in Nassau County. The practice phone is (516) 442-4077.

Dr. Manvar-Singh's primary practice is All Care Medical of NY, P.C. in New Hyde Park, New York. Dr. Manvar-Singh is also affiliated with Long Island Jewish Medical Center. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Manvar-Singh to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Manvar-Singh practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Manvar-Singh's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Manvar-Singh is licensed in New York.

CMS data shows 315 Medicare services from Dr. Manvar-Singh across 13 procedure codes in 2024, for 170 Medicare patients. Medicare paid $31,798 for them.

CMS counts 170 Medicare patients who saw Dr. Manvar-Singh in 2024. The largest group is 75 to 84, with 69 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 3.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Manvar-Singh's median patient age at 71, with 54% women.

In 2024, Dr. Manvar-Singh wrote 126 Medicare Part D claims for 44 patients. 79% of them were for generic drugs. CMS names the drug for 89 of them, across 3 drugs with 11 or more claims each, at $14,518 in total drug cost. In 2023, CMS named 205 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Manvar-Singh for performance year 2024, reported through an alternative payment model (APM). Dr. Manvar-Singh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 22 procedures of varicose vein removal by Dr. Manvar-Singh, more than 59% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Manvar-Singh, published from 2019 to 2024. 2023 was the busiest year, with 2. The most frequent topics are Endovascular Procedures and Carotid Stenosis. Dr. Manvar-Singh has published most often in Ann Vasc Surg. Dr. Manvar-Singh's most frequent co-authors are Yana Etkin, MD, Gregg S. Landis, MD and Kambhampaty Krishnasastry, MD.

CMS Open Payments shows 186 general payments to Dr. Manvar-Singh from 24 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 58% of the total. C. R. Bard, Inc. & Subsidiaries paid the most, $6,126.